Faculty
Activity Medical Director
Ann J. Brown, MD, MHS
Department of Medicine/Division of Endocrinology
Duke University Medical Center
Durham, North Carolina

Authors
Tracy L. Setji, MD
Department of Medicine/Division of Endocrinology
Duke University Medical Center
Durham, North Carolina

Katherine C. Pereira, MSN, FNP
Department of Medicine/Division of Endocrinology
Duke University Medical Center
Durham, North Carolina

M. Angelyn Bethel, MD
Department of Medicine/Division of Endocrinology
Duke University Medical Center
Durham, North Carolina

Angela F. Jarman
Department of Medicine/Division of Endocrinology
Duke University Medical Center
Durham, North Carolina

Staff and Content Validation Reviewer Disclosure
The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.

Resolution of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Faculty Disclosure
The following authors and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: Ann J. Brown, MD, MHS; Tracy L. Setji, MD; Katherine Pereira, MSN, FNP; Angela Jarman, BA; Anna Robinson Brodeur, BA.

The following authors and/or planning committee members have indicated they have relationships with industry to disclose relative to the content of this CME activity: M. Angelyn Bethel, MD, has indicated she is a speaker for Merck, Aventis Pharmaceutical. She is a co-investigator for Sanofi-aventis, Novartis.

Unapproved Use Disclosure
Duke School of Medicine requires CME faculty (authors) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA-approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.